Abstract:Hereditary spastic paraplegia (HSP) associated with thin corpus callosum (TCC) is an autosomal recessive complicated HSP characterized by normal motor development, followed by slowly progressive spastic paraparesis and mental deterioration. Recently, mutations of the SPG11 gene encoding the spatacsin protein have been identified as a major cause of HSP-TCC. SPG11 is located on chromosome 15q21.1, contains 40 exons and encodes a protein of 2,443 amino acids. Spatacsin function is not yet known, however, its widespread expression in the central nervous system and its highly conserved sequence among species indicate an important and essential role. Up to date, 10 mutations including four nonsense mutations, four small deletions and two small insertions of the SPG11 gene were found in 12 families of ARHSP-TCC. Here, we described two novel mutations of the SPG11 gene in two unrelated Chinese patients with HSP-TCC. Patient 1, a 24-year-old man, presented with a progressive speech disorder with mental deterioration impairing school performance(s) from the age of 7 years on. From the age of 14 onwards, he also developed leg stiffness and gait disturbance. There was no consanguinity, family history was unremarkable, and his birth and motor development had been normal. Neurologic examination at age 24 showed dysarthria, left foot muscle atrophy, lower limb symmetric spasticity, upper limb ataxia, and unsteady tandem walking. His Mini Mental State Examination (MMSE) score was 14/30. Ceruloplasmin was normal. Motor nerve conduction of the left peroneal nerve showed lowered amplitude. EMG examination showed denervation potentials in the anterior tibial muscles and the left gastrocnemius muscle. Brain MR Images (Fig 1a–c) disclosed thinning of the corpus callosum, especially in its anterior parts, slight hyperintense signal alterations in the periventricular white matter, as well as mild thalamic and cerebellar atrophy. Spinal cord MRI was normal. Patient 2, a 26-year-old man, born from consanguineous parents, suffered from slowly progessive dysarthria, accompanied by a gait disorder from the age of 18 onwards. He had difficulty in walking without assistance by the age of 23. His MMSE score was 6/30. Besides the dysarthria, and paraspasticity, there was additional hand muscle atrophy, and mild weakness of the lower limbs. Nerve conduction was normal. In the brain MRI (Fig 1d–f) there was slight enlargement of the lateral ventricles and a thin corpus callosum. Spine MRI revealed atrophy of the thoracic cord. Some of the dysarthria and spasticity symptoms of the patients improved under treatment with baclofen (45 mg/day) and D2 receptor agonist (Piribedil, 50 mg bid). Sequencing of the SPG11 gene revealed a novel homozygous small deletion (c.4307_4308del, Fig. 2A) in exon 25 in the first patient leading to a frameshift and early termination at amino acid residue 1,442. This was not found in 100 control chromosomes studied by direct sequencing (Fig. 2B). A homozygous c.5977C>T substitution was found in exon 31 in the second patient (Fig. 2C), leading to a termination at amino acid residue 1,993. All PCR products of exon 31 of 50 healthy controls were cut into 210 bp and 320 bp with Sall (Fig. 2E). This restriction site which is found in normal chromosomes was lost in patient 2. A homozygous c.833A>G substitution was also detected in exon 5 of the same patient (Fig. 2F), leading to an amino acid change (p.278N>S). This is likely a polymorphism since 4 out of 50 healthy controls were heterozygote for the same change (Fig. 2G). The two novel mutations found in the present report lead to a stop codon, providing further evidence for a loss of function mechanism. The difference of the severity and onset age of these two patients may be due to differences in spatacsin dysfunction resulting from the two mutations. However, a precise genotype-phenotype correlation is not yet possible, due to the small overall number of patients with SPG11 mutations described so far. This report points to the importance of screening the SPG11 gene for additional mutations in more families with HSP-TCC.

Complicated Hereditary Spastic Paraplegia Caused by SERAC1 Variants in a Chinese Family

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

SERAC1 Deficiency- A New Phenotype.

MEGDHEL syndrome caused by SERAC1 gene variation: a case report and literature review

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Novel Mutations C.[5121_5122insag]+[6859c>t] of the SPG11 Gene Associated with Cerebellum Hypometabolism in a Chinese Case of Hereditary Spastic Paraplegia with Thin Corpus Callosum.

Infantile‐onset CMT2D/dSMA‐V in a Chinese Family with Parental Germline Mosaicism for a Novel Mutation in the GARS1 Gene

Canine Multiple System Degeneration Associated with Sequence Variants in SERAC1

Microdeletion in Distal PLP1 Enhancers Causes Hereditary Spastic Paraplegia 2.

Novel compound heterozygous variants (c.971delA/c.542C > T) in SLC1A4 causes spastic tetraplegia, thin corpus callosum, and progressive microcephaly: a case report and mutational analysis

[Clinical and Genetic Analysis of a Family with Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation].

Two Novel Mutations in the SPG11 Gene Causing Hereditary Spastic Paraplegia Associated with Thin Corpus Callosum

[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Canavan disease]

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene

Exome Sequencing Identifies a Mutation (Y740C) in Spastic Paraplegia 7 Gene Associated with Adult-Onset Primary Lateral Sclerosis in a Chinese Family.

Identification of Novel SPG11 Mutations in a Cohort of Chinese Families with Hereditary Spastic Paraplegia.

Tremor as an early sign of hereditary spastic paraplegia due to mutations in ALDH18A1

Chinese Families with Autosomal Recessive Hereditary Spastic Paraplegia Caused by Mutations in SPG11

Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia

Previously Undescribed Gross HACE1 Deletions as a Cause of Autosomal Recessive Spastic Paraplegia